Changes have been implemented at Puget Sound Blood Center (PSBC) to streamline the senior leadership team. Moving forward, there’s a sharpened focus on effectively implementing business strategies, fully delivering on customer expectations, maintaining full regulatory compliance and actively pursuing continuous quality improvement.
David Fennell has become chief operating officer in addition to his role as chief information officer. Fennell’s leadership experience includes nearly three decades with Boeing Company and three years at the Bill and Melinda Gates Foundation, providing a unique perspective and insight that blends business and non-profit experience. All operational business lines, related sales support and project management will report through him.
Dr. Thomas Price has announced his plan to retire from PSBC on October 1 after 37 years of distinguished service, including 20 years as medical director. Price played a defining leadership role at the Blood Center, overseeing all medical activities as well as in launching our apheresis program and spearheading advancements in both donor and therapeutic apheresis research. His contributions and leadership are recognized nationally and internationally. He led the PSBC Cord Blood Program for more than a decade and served on many boards, including the National Bone Marrow Program and more recently the Advisory Council on Stem Cell Transplantation of DHHS. Price shared his knowledge and experience with generations of new physicians as a faculty member of the UW School of Medicine and through more than 100 published scientific articles. Dr. Theresa Nester will serve as interim Chief Medical Officer while we conduct a national search for this position.
Sally Sullivan retains responsibility for Human Resources while also assuming responsibility for Lean initiatives, marketing and communications.